RATIONALE: Mechanical ventilation with high VT (HVT) progressively leads to lung injury and decreased efficiency of gas exchange. Hypoxic pulmonary vasoconstriction (HPV) directs blood flow to well-ventilated lung regions, preserving systemic oxygenation during pulmonary injury. Recent experimental studies have revealed an important role for leukotriene (LT) biosynthesis by 5-lipoxygenase (5LO) in the impairment of HPV by endotoxin. OBJECTIVES: To investigate whether or not impairment of HPV contributes to the hypoxemia associated with HVT and to evaluate the role of LTs in ventilator-induced lung injury. METHODS: We studied wild-type and 5LO-deficient mice ventilated for up to 10 hours with low VT (LVT) or HVT. RESULTS: In wild-type mice, HVT, but not LVT, increased pulmonary vascular permeability and edema formation, impaired systemic oxygenation, and reduced survival. HPV, as reflected by the increase in left pulmonary vascular resistance induced by left mainstem bronchus occlusion, was markedly impaired in animals ventilated with HVT. HVT ventilation increased bronchoalveolar lavage levels of LTs and neutrophils. In 5LO-deficient mice, the HVT-induced increase of pulmonary vascular permeability and worsening of respiratory mechanics were markedly attenuated, systemic oxygenation was preserved, and survival increased. Moreover, in 5LO-deficient mice, HVT ventilation did not impair the ability of left mainstem bronchus occlusion to increase left pulmonary vascular resistance. Administration of MK886, a 5LO-activity inhibitor, or MK571, a selective cysteinyl-LT(1) receptor antagonist, largely prevented ventilator-induced lung injury. CONCLUSIONS: These results indicate that LTs play a central role in the lung injury and impaired oxygenation induced by HVT ventilation.
RATIONALE: Mechanical ventilation with high VT (HVT) progressively leads to lung injury and decreased efficiency of gas exchange. Hypoxic pulmonary vasoconstriction (HPV) directs blood flow to well-ventilated lung regions, preserving systemic oxygenation during pulmonary injury. Recent experimental studies have revealed an important role for leukotriene (LT) biosynthesis by 5-lipoxygenase (5LO) in the impairment of HPV by endotoxin. OBJECTIVES: To investigate whether or not impairment of HPV contributes to the hypoxemia associated with HVT and to evaluate the role of LTs in ventilator-induced lung injury. METHODS: We studied wild-type and 5LO-deficient mice ventilated for up to 10 hours with low VT (LVT) or HVT. RESULTS: In wild-type mice, HVT, but not LVT, increased pulmonary vascular permeability and edema formation, impaired systemic oxygenation, and reduced survival. HPV, as reflected by the increase in left pulmonary vascular resistance induced by left mainstem bronchus occlusion, was markedly impaired in animals ventilated with HVT. HVT ventilation increased bronchoalveolar lavage levels of LTs and neutrophils. In 5LO-deficient mice, the HVT-induced increase of pulmonary vascular permeability and worsening of respiratory mechanics were markedly attenuated, systemic oxygenation was preserved, and survival increased. Moreover, in 5LO-deficient mice, HVT ventilation did not impair the ability of left mainstem bronchus occlusion to increase left pulmonary vascular resistance. Administration of MK886, a 5LO-activity inhibitor, or MK571, a selective cysteinyl-LT(1) receptor antagonist, largely prevented ventilator-induced lung injury. CONCLUSIONS: These results indicate that LTs play a central role in the lung injury and impaired oxygenation induced by HVT ventilation.
Authors: F Ichinose; W M Zapol; A Sapirstein; R Ullrich; A M Tager; K Coggins; R Jones; K D Bloch Journal: Circ Res Date: 2001-04-27 Impact factor: 17.367
Authors: Clinton H Doerr; Ognjen Gajic; Jorge C Berrios; Sean Caples; Matthew Abdel; James F Lymp; Rolf D Hubmayr Journal: Am J Respir Crit Care Med Date: 2005-02-01 Impact factor: 21.405
Authors: Michael R Wilson; Sharmila Choudhury; Michael E Goddard; Kieran P O'Dea; Andrew G Nicholson; Masao Takata Journal: J Appl Physiol (1985) Date: 2003-06-13
Authors: Pietro Caironi; Thomas Langer; Eleonora Carlesso; Alessandro Protti; Luciano Gattinoni Journal: Intensive Care Med Date: 2011-11-04 Impact factor: 17.440
Authors: Margit V Szabari; Kazue Takahashi; Yan Feng; Joseph J Locascio; Wei Chao; Edward A Carter; Marcos F Vidal Melo; Guido Musch Journal: Am J Respir Cell Mol Biol Date: 2019-02 Impact factor: 6.914
Authors: Rebecca M Baron; Alexander J S Choi; Caroline A Owen; Augustine M K Choi Journal: Am J Physiol Lung Cell Mol Physiol Date: 2011-12-23 Impact factor: 5.464
Authors: Mauro R Tucci; Eduardo L V Costa; Tyler J Wellman; Guido Musch; Tilo Winkler; R Scott Harris; Jose G Venegas; Marcelo B P Amato; Marcos F Vidal Melo Journal: Anesthesiology Date: 2013-07 Impact factor: 7.892
Authors: George D Leikauf; Vincent J Concel; Kiflai Bein; Pengyuan Liu; Annerose Berndt; Timothy M Martin; Koustav Ganguly; An Soo Jang; Kelly A Brant; Richard A Dopico; Swapna Upadhyay; Clinton Cario; Y P Peter Di; Louis J Vuga; Emrah Kostem; Eleazar Eskin; Ming You; Naftali Kaminski; Daniel R Prows; Daren L Knoell; James P Fabisiak Journal: Am J Respir Cell Mol Biol Date: 2013-09 Impact factor: 6.914
Authors: Alexander Zarbock; Matthew R Distasi; Emily Smith; John M Sanders; Gerhard Kronke; Brian L Harry; Sibylle von Vietinghoff; Konrad Buscher; Jerry L Nadler; Klaus Ley Journal: J Immunol Date: 2009-09-14 Impact factor: 5.422